الوصف

Myriocin content in Cordyceps fungal preparations is characterized, confirming the presence of the SPT-inhibiting compound as the likely active component.

Figure 12

Chart

Source Paper

Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis.

Scientific reports (2022)

PMID: 35508667

DOI: 10.1038/s41598-022-11219-3

Cite This Figure

![Figure 12: Myriocin content in Cordyceps fungal preparations is characterized, confirming the presence of the SPT-inhibiting compound as the likely active component.]()

> Source: Ying Li et al. "Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hep." *Scientific reports*, 2022. PMID: [35508667](https://pubmed.ncbi.nlm.nih.gov/35508667/)

<figure>
  <img src="" alt="Myriocin content in Cordyceps fungal preparations is characterized, confirming the presence of the SPT-inhibiting compound as the likely active component." />
  <figcaption>Figure 12. Myriocin content in Cordyceps fungal preparations is characterized, confirming the presence of the SPT-inhibiting compound as the likely active component.<br>  Source: Ying Li et al. "Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hep." <em>Scientific reports</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35508667/">35508667</a></figcaption>
</figure>

أدلة ذات صلة

CLA لـ Obesity

التقييم B · 18 دراسات